FDA won’t review Moderna’s application for first mRNA-based flu vaccine - The Washington Post
Source:The Washington Post
The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.
Related Articles
Warren Buffett's successor eyes selling off Berkshire Hathaway's 325 million Kraft Heinz shares - AP News
Warren Buffett’s successor appears to be considering his first significant move after taking over as …
Donald Trump Endorses Nexstar-Tegna Merger, And FCC Chair Responds: “Let’s Get It Done” - Deadline
The merger is still undergoing an FCC review.
Supreme Court will review Monsanto’s bid for immunity in Roundup lawsuits - The Washington Post
The Supreme Court will consider an appeal by the manufacturer of Roundup weed killer over suits that …
Donald Trump preparing to nominate Kevin Warsh as Federal Reserve chair - Financial Times
US president says he will announce nominee to replace Jay Powell on Friday morning